In stroke and other cerebrovascular conditions, impaired CTLA-4 expression can lead to excessive inflammation, while CTLA-4 activation via regulatory T cells supports neuroprotection and offers a promising target for immunomodulatory therapies [11]. This evidence concerns the gene CTLA4 and stroke disorder.